A fundamental discovery by University of Missouri scientists could help solve one of the most frustrating challenges in ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

Recent research on MCL-1, a critical protein that is an attractive target for cancer drug development, helps explain why some ...

A new drug targets RAS-PI3Kα pathways without harmful side effects. It was developed using high-performance computing and AI.

These models can shed light on the fundamental biological processes behind milk production, tissue regeneration and the early ...

These and other 3D organoid models developed by Predictive Oncology substantially complement its AI-driven 2D platform and 3D spheroids, which utilize human tumor samples to accelerate drug ...

Detailed price information for Laboratory Corp of America Holdings (LH-N) from The Globe and Mail including charting and trades.

The Wellcome Sanger Institute, Parse Biosciences, and the Computational Health Center at Helmholtz Munich today announced a collaboration to build the foundation of a single cell atlas, focused on ...

METscreen is cancer organoid-based and provides direct measurement of organoids’ viability after exposure to a drug panel and related dose response. In addition to standardized viability assays, ...

Signet’s organoid models, derived from real-world cancer genomics data, can closely mimic human biology in 3D tissues to identify novel targets and evaluate drug efficacy with greater clinical ...